Key facts
- It has raised $13.8M across 4 recorded rounds; the latest was Buyout/LBO (Add-on)† in Jun 2025.
- Medxoom has filed 3 Form Ds with the SEC since 2019, most recently Oct 2022 ($2.4M sold to 5 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for Medxoom
Create free account
No card required
Funding rounds
4 roundsJun 2025Buyout/LBO (Add-on)†—▮
About Medxoom
- Industry
- Other Healthcare Technology Systems
PA Mark — not yet priced
Medxoom doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Medxoom shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Medxoom in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.